AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE1089.4519.45 (+1.82 %)
PREV CLOSE ( ) 1070.00
OPEN PRICE ( ) 1071.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 131296
TODAY'S LOW / HIGH ( )1064.75 1095.00
52 WK LOW / HIGH ( )498.7 1177
NSE1088.7518.4 (+1.72 %)
PREV CLOSE( ) 1070.35
OPEN PRICE ( ) 1070.35
BID PRICE (QTY) 1088.75 (1104)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2060466
TODAY'S LOW / HIGH( ) 1064.05 1099.25
52 WK LOW / HIGH ( )498.35 1177.1

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.